bluebird bio Inc. · Industry Biotechnology · Sector Health Care/Life Sciences · Fiscal Year-end 12/ · Revenue $M · Net Income -$M · Sales Growth -. BLUE Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Earnings have grown % per year. bluebird bio (BLUE) has a Smart Score of 1 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. bluebird bio Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. --(BUSINESS WIRE)--Dec. 19, bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today announced the pricing of its underwritten public offering of 83,,

Get bluebird bio Inc (BLUE.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. bluebird bio Inc. ; FY Estimate Trends · -$ · -$ ; FY Estimate Trends · -$ · -$ ; Q4 Estimate Trends · -$ · -$ ; Q1 Estimate. Get bluebird bio Inc (BLUE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. A high-level overview of bluebird bio, Inc. (BLUE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Stock Activity ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High: The latest bluebird bio stock prices, stock quotes, news, and BLUE history to help you invest and trade smarter. Bluebird bio Stock Gained % Tuesday. It's Still 'Remarkably Undervalued,' Analyst Says. Bluebird Bio's Gene Therapy Is $ Million Per Patient. The Stock. In the last 3 years, BLUE stock traded as high as $ and as low as $ What are the top ETFs holding Bluebird Bio? The top ETF. Price Target Upside/Downside. According to analysts' consensus price target of $, bluebird bio has a forecasted upside of % from its current price of. Stock analysis for Bluebird Bio Inc (BLUE:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene.

bluebird bio Stock forecast & analyst price target predictions based on 8 analysts offering months price targets for BLUE in the last 3 months. BLUE | Complete bluebird bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the latest bluebird bio Inc. (BLUE) stock price, news, historical charts, analyst ratings and financial information from WSJ. See the latest bluebird bio Inc stock price (BLUE:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Key Data ; 52 Week High/Low, $/$ ; Market Cap, ,, ; Forward P/E 1 Yr. ; Earnings Per Share(EPS), $ View the BLUE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bluebird bio Inc real. Real time Bluebird Bio (BLUE) stock price quote, stock graph, news & analysis. Get bluebird bio Inc (BLUE.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders.

In depth view into BLUE (bluebird bio) stock including the latest price, news, dividend history, earnings information and financials. BLUE (Common Stock). Exchange, NASDAQ GS (US Dollar). Price, $ Change (%), 0 (%). Volume, , Today's Open, Previous Close, $ bluebird bio, Inc. (ucheba-service.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock bluebird bio, Inc. | Nasdaq: BLUE. (NASDAQ: BLUE) Bluebird Bio currently has ,, outstanding shares. With Bluebird Bio stock trading at $ per share, the total value of Bluebird Bio. The stock price has decreased by % in the last 52 weeks. The beta is , so bluebird bio's price volatility has been lower than the market average. Beta.

bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.

orc dividend history | ock market

16 17 18 19 20

Copyright 2013-2024 Privice Policy Contacts